Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Halozyme Therapeutics (NASDAQ:HALO). While ...

The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune ...

Halozyme Therapeutics (NASDAQ:HALO) announced on Wednesday that the European Commission has approved an injectable combo ...

Learn more about whether Alvotech or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Halozyme (HALO) says the European Commission OK'd an injectable version of J&J's (JNJ) cancer drug, Rybrevant for certain ...

Halozyme announces US FDA approval of argenx's Vyvgart Hytrulo prefilled syringe co-formulated with ENHANZE for self-injection for gMG and CIDP: San Diego Monday, April 14, 2025, ...

Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received European Commission approval for an ...

The company’s product pipeline and regulatory situation make it primed for growth. Halozyme’s fourth-quarter fiscal 2024 earnings report showed that it passed $1 billion in annual revenue for ...

CIBC Private Wealth Group LLC lessened its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 99.7% in ...

Halozyme Therapeutics (HALO) announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products ...

Learn more about whether Halozyme Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.